A Pusan National University study has identified a signalling pathway [...]

Hansa Biopharma has treated the first commercial Australian living donor [...]

NICE has recommended glycopyrronium bromide cream as an option for [...]

NICE has recommended sublingual immunotherapy tablets for children with moderate [...]

Tris Pharma has announced partnerships with Calm Health and ADHD [...]

The FDA has accepted Belite Bio’s application for tinlarebant and [...]

Skylark Bio has dosed the first patient in a Phase [...]

The FDA has approved Moderna’s mRNA seasonal influenza vaccine mFLUSIVA [...]

Vaderis Therapeutics has raised $152M and started a global Phase [...]

AC Immune has received FDA Fast Track designation and IND [...]